{
    "2019-06-26": [
        [
            {
                "time": "2019-06-26",
                "original_text": "利空出尽+估值切换，医药板块年底或迎新一轮上涨趋势",
                "features": {
                    "keywords": [
                        "利空出尽",
                        "估值切换",
                        "医药板块",
                        "上涨趋势"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "外资动向 | 北向资金减仓A股 沪深股通净流出9.44亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "减仓",
                        "沪深股通",
                        "净流出"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "海外医药新闻发布20190626【西南医药朱国广陈铁林团队】",
                "features": {
                    "keywords": [
                        "海外医药",
                        "新闻",
                        "西南医药",
                        "朱国广",
                        "陈铁林"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "商誉超88亿的复星医药，拟7.4亿收购力思特",
                "features": {
                    "keywords": [
                        "复星医药",
                        "商誉",
                        "收购",
                        "力思特"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "港股午盘基本平收 零售股、医药股现强势",
                "features": {
                    "keywords": [
                        "港股",
                        "午盘",
                        "零售股",
                        "医药股",
                        "强势"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "零售"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "医药板块表现强势，机构：不惧政策扰动，把握高确定性投资主线",
                "features": {
                    "keywords": [
                        "医药板块",
                        "强势",
                        "政策扰动",
                        "高确定性",
                        "投资主线"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "中信证券清仓减持中信建投；新纶科技涉信披违规被证监会立案调查",
                "features": {
                    "keywords": [
                        "中信证券",
                        "清仓减持",
                        "中信建投",
                        "新纶科技",
                        "信披违规",
                        "证监会",
                        "立案调查"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}